Skip to main content

Advertisement

Log in

Anti-Saccharomyces cerevisiae Antibody in Intestinal Behçet’s Disease Patients: Relation to Clinical Course

  • Published:
Diseases of the Colon & Rectum

Purpose

This study was designed to assess anti-Saccharomyces cerevisiae antibody positive rate in Behçet’s disease and intestinal Behçet’s disease and to evaluate whether anti-Saccharomyces cerevisiae antibody expression is associated with clinical findings at diagnosis and clinical course of intestinal Behçet’s disease.

Methods

One hundred six patients with intestinal Behçet’s disease, 30 patients with Behçet’s disease, and 45 healthy control subjects were included. Anti-Saccharomyces cerevisiae antibody was detected by indirect immunofluorescence assay. According to anti-Saccharomyces cerevisiae antibody expression, the various parameters at diagnosis, cumulative relapse rates, and cumulative probabilities of operation were analyzed.

Results

Anti-Saccharomyces cerevisiae antibody positive rate was 44.3 percent in intestinal Behçet’s disease, 3.3 percent in Behçet’s disease, and 8.8 percent in healthy control subjects. In patients with intestinal Behçet’s disease, age, gender, distribution of Behçet’s disease subtype, symptoms, laboratory tests, and colonoscopic findings at diagnosis were not different according to anti-Saccharomyces cerevisiae antibody expression. Cumulative probability of a first operation was significantly higher in anti-Saccharomyces cerevisiae antibody (+) intestinal Behçet’s disease than in anti-Saccharomyces cerevisiae antibody (−) intestinal Behçet’s disease: 44.8 and 17.2 percent at one year, and 53 and 24.3 percent at two years after diagnosis, respectively (P = 0.006). The number of patients who underwent two or more operations was higher in anti-Saccharomyces cerevisiae antibody (+) intestinal Behçet’s disease than in anti-Saccharomyces cerevisiae antibody (−) intestinal Behçet’s disease (21.3 vs. 8.5 percent). The cumulative relapse rates were not different between the two groups.

Conclusions

Anti-Saccharomyces cerevisiae antibody positive rate was 44.3 percent in intestinal Behçet’s disease. Clinical findings at diagnosis and cumulative relapse rates of intestinal Behçet’s disease were not found to be associated with anti-Saccharomyces cerevisiae antibody expression. However, patients with anti-Saccharomyces cerevisiae antibody (+) intestinal Behçet’s disease were more likely to receive surgical treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. H Behçet (1937) ArticleTitleUber rezidivierende aphthose, durch ein Virus verursachte Geschwure am Auge und an den Genitalien Dermatol Wschr 105 1152–1157

    Google Scholar 

  2. JD O’Duffy JA Carney S Deodhar (1971) ArticleTitleBehçet’s disease. Report of 10 cases, 3 with new manifestations Ann Intern Med 75 561–570 Occurrence Handle5109888 Occurrence Handle1:STN:280:CS2D3czgsFc%3D

    PubMed  CAS  Google Scholar 

  3. T Chajek M Fainaru (1975) ArticleTitleBehçet’s disease. Report of 41 cases and a review of the literature Medicine 54 179–196 Occurrence Handle1095889 Occurrence Handle1:STN:280:DyaE2M7ptl2ltw%3D%3D Occurrence Handle10.1097/00005792-197505000-00001

    Article  PubMed  CAS  Google Scholar 

  4. JD O’Duffy (1994) ArticleTitleBehçet’s disease Curr Opin Rheumatol 6 39–43 Occurrence Handle8031678 Occurrence Handle1:STN:280:ByuA3cvntlI%3D Occurrence Handle10.1097/00002281-199401000-00007

    Article  PubMed  CAS  Google Scholar 

  5. VG Kaklamani G Vaiopoulos PG Kaklamanis (1998) ArticleTitleBehçet’s disease Semin Arthritis Rheum 27 197–217 Occurrence Handle9514126 Occurrence Handle1:STN:280:DyaK1c7ntlSmuw%3D%3D Occurrence Handle10.1016/S0049-0172(98)80001-2

    Article  PubMed  CAS  Google Scholar 

  6. T Sakane M Takeno N Suzuki G Inaba (1999) ArticleTitleBehçet’s disease N Engl J Med 341 1284–1291 Occurrence Handle10528040 Occurrence Handle1:STN:280:DyaK1Mvkt1aktg%3D%3D Occurrence Handle10.1056/NEJM199910213411707

    Article  PubMed  CAS  Google Scholar 

  7. Y Kasahara S Tanaka M Nishino H Umemura S Shiraha T Kuyama (1981) ArticleTitleIntestinal involvement in Behçet’s disease: review of 136 surgical cases in the Japanese literature Dis Colon Rectum 24 103–106 Occurrence Handle7215071 Occurrence Handle1:STN:280:DyaL3M7mtlyquw%3D%3D

    PubMed  CAS  Google Scholar 

  8. S Yurdakul N Tuzuner I Yurdakul V Hamuryudan H Yazici (1996) ArticleTitleGastrointestinal involvement in Behçet’s syndrome: a controlled study Ann Rheum Dis 55 208–210 Occurrence Handle8712889 Occurrence Handle1:STN:280:DyaK283ks1Cmsw%3D%3D

    PubMed  CAS  Google Scholar 

  9. H Yazici CG Barnes (1991) ArticleTitlePractical treatment recommendations for pharmacotherapy of Behçet’s syndrome Drugs 42 796–804 Occurrence Handle1723375 Occurrence Handle1:STN:280:DyaK387jslSksg%3D%3D

    PubMed  CAS  Google Scholar 

  10. M Peeters S Joossens S Vermeire R Vlietinck X Bossuyt P Rutgeerts (2001) ArticleTitleDiagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease Am J Gastroenterol 96 730–734 Occurrence Handle11280542 Occurrence Handle1:STN:280:DC%2BD3M7ovFOktg%3D%3D Occurrence Handle10.1111/j.1572-0241.2001.03613.x

    Article  PubMed  CAS  Google Scholar 

  11. A Saxon F Shanahan C Landers T Ganz S Targan (1990) ArticleTitleA distinct subset of antineutrophil anticytoplasmic antibodies is associated with inflammatory bowel disease J Allergy Clin Immunol 86 202–210 Occurrence Handle2200820 Occurrence Handle1:STN:280:DyaK3czkslWntQ%3D%3D Occurrence Handle10.1016/S0091-6749(05)80067-3

    Article  PubMed  CAS  Google Scholar 

  12. CH Choi WH Kim TI Kim et al. (2003) ArticleTitleAntineutrophil cytoplasmic antibody in patients with ulcerative colitis: relation to clinical course Gastroenterology 124 IssueIDSuppl 1 A216 Occurrence Handle10.1016/S0016-5085(03)81083-1

    Article  Google Scholar 

  13. B Sendid JF Colombel PM Jacquinot et al. (1996) ArticleTitleSpecific antibody response to oligomannosidic epitopes in Crohn’s disease Clin Diagn Lab Immunol 3 219–226 Occurrence Handle8991640 Occurrence Handle1:CAS:528:DyaK28Xitlaiurg%3D

    PubMed  CAS  Google Scholar 

  14. FM Ruemmele SR Targan G Levy M Dubinski J Braun EG Seidman (1998) ArticleTitleDiagnostic accuracy of serological assays in pediatric inflammatory bowel disease Gastroenterology 115 822–829 Occurrence Handle9753483 Occurrence Handle1:STN:280:DyaK1cvis1ehsw%3D%3D Occurrence Handle10.1016/S0016-5085(98)70252-5

    Article  PubMed  CAS  Google Scholar 

  15. JF Quinton B Sendid D Reumaux et al. (1998) ArticleTitleAnti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role Gut 42 788–791 Occurrence Handle9691915 Occurrence Handle1:CAS:528:DyaK1cXlslChs7o%3D Occurrence Handle10.1136/gut.42.6.788

    Article  PubMed  CAS  Google Scholar 

  16. Y Mizushima G Inaba Y Mimura S Ono (1988) ArticleTitleDiagnostic criteria for Behçet’s disease in 1987, and guidelines for treating Behçet’s disease Saishin Igaku 43 382–391

    Google Scholar 

  17. CR Lee WH Kim YS Cho et al. (2001) ArticleTitleColonoscopic findings in intestinal Behçet’s disease Inflamm Bowel Dis 7 243–249 Occurrence Handle11515851 Occurrence Handle1:STN:280:DC%2BD3MvntFShtA%3D%3D Occurrence Handle10.1097/00054725-200108000-00010

    Article  PubMed  CAS  Google Scholar 

  18. H Malchow K Ewe JW Brandes (1984) ArticleTitleEuropean Cooperative Crohn’s Disease Study (ECCDS): result of drug treatment Gastroenterology 86 249–266 Occurrence Handle6140202 Occurrence Handle1:STN:280:DyaL2c%2FosFOisg%3D%3D

    PubMed  CAS  Google Scholar 

  19. T Yao (1996) ArticleTitleNew criteria for the diagnosis of Crohn’s disease I To Cho 31 451–464

    Google Scholar 

  20. MM Oken RH Creech DC Tormey et al. (1982) ArticleTitleToxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 649–655 Occurrence Handle7165009 Occurrence Handle1:STN:280:DyaL3s7kvFOgsw%3D%3D

    PubMed  CAS  Google Scholar 

  21. LL Ketch CA Buerk D Liechty (1980) ArticleTitleSurgical implications of Behçet’s disease Arch Surg 115 759–760 Occurrence Handle6966918 Occurrence Handle1:STN:280:DyaL3c3hvFGgtA%3D%3D

    PubMed  CAS  Google Scholar 

  22. I Sayek O Aran B Uzunalimoglu E Hersek (1991) ArticleTitleIntestinal Behçet’s disease: surgical experience in seven cases Hepatogastroenterology 38 81–83 Occurrence Handle2026395 Occurrence Handle1:STN:280:DyaK3M3isVGqug%3D%3D

    PubMed  CAS  Google Scholar 

  23. S Tsukada T Yamazaki S Iyo et al. (1964) ArticleTitleNeuro-Behçet’s syndrome: report of two cases and review of the literature Saishin Igaku 19 1533–1541

    Google Scholar 

  24. T Lehner (1977) ArticleTitleOral ulceration and Behçet’s syndrome Gut 18 491–511 Occurrence Handle326640 Occurrence Handle1:STN:280:DyaE2s3gsFKktQ%3D%3D

    PubMed  CAS  Google Scholar 

  25. T Shimizu GE Ehrlich G Inaba et al. (1979) ArticleTitleBehçet’s disease (Behçet’s syndrome) Semin Arthritis Rheum 8 223–260 Occurrence Handle382361 Occurrence Handle1:STN:280:DyaE1M3kvVylsA%3D%3D Occurrence Handle10.1016/0049-0172(79)90004-0

    Article  PubMed  CAS  Google Scholar 

  26. Y Bayraktar E Özaslan DH Thiel ParticleVan (2000) ArticleTitleGastrointestinal manifestations of Behçet’s disease J Clin Gastroenterol 30 144–154 Occurrence Handle10730919 Occurrence Handle1:STN:280:DC%2BD3c7ptlWrtw%3D%3D Occurrence Handle10.1097/00004836-200003000-00006

    Article  PubMed  CAS  Google Scholar 

  27. S Baba M Maruta K Ando T Teramoto I Endo (1976) ArticleTitleIntestinal Behçet’s disease: report of five cases Dis Colon Rectum 19 428–440 Occurrence Handle939158 Occurrence Handle1:STN:280:DyaE283jsFSitg%3D%3D

    PubMed  CAS  Google Scholar 

  28. CC Zouboulis I Kotter D Djawari et al. (1997) ArticleTitleEpidemiological features of Adamantiades: Behçet’s disease in Germany and in Europe Yonsei Med J 38 411–422 Occurrence Handle9509911 Occurrence Handle1:STN:280:DyaK1c7ntVKlsA%3D%3D

    PubMed  CAS  Google Scholar 

  29. Y Oshima T Shimizu R Yokohari et al. (1963) ArticleTitleClinical studies on Behçet’s syndrome Ann Rheum Dis 22 36–45 Occurrence Handle10.1136/ard.22.1.36 Occurrence Handle18623869 Occurrence Handle1:STN:280:DC%2BD1crjt1Wrug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  30. HK Ha HJ Lee SK Yang et al. (1998) ArticleTitleIntestinal Behçet syndrome: CT features of patients with and patients without complications Radiology 209 449–454 Occurrence Handle9807572 Occurrence Handle1:STN:280:DyaK1M%2FisVOjtg%3D%3D

    PubMed  CAS  Google Scholar 

  31. GR Barclay H McKenzie J Pennington D Parratt CR Pennington (1992) ArticleTitleThe effect of dietary yeast on the activity of stable chronic Crohn’s disease Scand J Gastroenterol 27 196–200 Occurrence Handle1502481 Occurrence Handle1:STN:280:DyaK38zms12jtA%3D%3D

    PubMed  CAS  Google Scholar 

  32. F Seibold S Brandwein S Simpson CO Elson (1998) ArticleTitlepANCA represent a cross-reactivity to enteric bacterial antigens J Clin Immunol 1823 153–160 Occurrence Handle10.1023/A:1023203118100

    Article  Google Scholar 

  33. JA Rump J Scholmerich V Gross et al. (1990) ArticleTitleA new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn’s disease Immunobiology 181 406–413 Occurrence Handle2099908 Occurrence Handle1:STN:280:DyaK3M3ptlymsg%3D%3D

    PubMed  CAS  Google Scholar 

  34. G Cambridge DS Rampton TR Stevens DA McCarthy M Kamm B Leaker (1992) ArticleTitleAnti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role Gut 33 668–674 Occurrence Handle1612485 Occurrence Handle1:STN:280:DyaK38zgslCqsw%3D%3D

    PubMed  CAS  Google Scholar 

  35. RH Duerr SR Targan CJ Landers et al. (1992) ArticleTitleAnti-neutrophil cytoplasmic antibodies in ulcerative colitis: Comparison with other colitides/diarrheal illnesses Gastroenterology 100 1590–1596

    Google Scholar 

  36. WJ Sandborn EV Loftus JF Colombel et al. (2001) ArticleTitleEvaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn’s Disease Inflamm Bowel Dis 7 192–201 Occurrence Handle11515844 Occurrence Handle1:STN:280:DC%2BD3MvntFSiuw%3D%3D Occurrence Handle10.1097/00054725-200108000-00003

    Article  PubMed  CAS  Google Scholar 

  37. WJ Sandborn CJ Landers WJ Tremaine et al. (1996) ArticleTitleAssociation of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study Mayo Clin Proc 71 431–436 Occurrence Handle8628021 Occurrence Handle1:STN:280:DyaK283ht1yrsQ%3D%3D Occurrence Handle10.4065/71.5.431

    Article  PubMed  CAS  Google Scholar 

  38. PR Fleshner EA Vasiliauskas LY Kam et al. (2001) ArticleTitleHigh level perinuclear antineutrophil cytoplasmic antibody (p-ANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis Gut 49 671–677 Occurrence Handle11600470 Occurrence Handle1:STN:280:DC%2BD3MrltlKmuw%3D%3D Occurrence Handle10.1136/gut.49.5.671

    Article  PubMed  CAS  Google Scholar 

  39. J Main H McKenzie GR Yeaman et al. (1988) ArticleTitleAntibody to Saccharomyces cerevisiae (baker’s yeast) Crohn’s disease BMJ 297 1105–1106 Occurrence Handle3143445 Occurrence Handle1:STN:280:DyaL1M%2Fmt1yisQ%3D%3D Occurrence Handle10.1136/bmj.297.6656.1105

    Article  PubMed  CAS  Google Scholar 

  40. U Sander I Kunze M Broker G Kunze (1998) ArticleTitleHumoral immune response to a 200-kDA glycoprotein antigen of Saccharomyces cerevisiae is common in man Immunol Lett 61 113–117 Occurrence Handle9657263 Occurrence Handle1:CAS:528:DyaK1cXjs1WrsL4%3D Occurrence Handle10.1016/S0165-2478(98)00003-0

    Article  PubMed  CAS  Google Scholar 

  41. EA Vasiliauskas LY Kam LC Karp et al. (2000) ArticleTitleMarker antibody expression stratifies Crohn’s disease into immunologically homogeneous subgroups with distinct clinical characteristics Gut 47 487–496 Occurrence Handle10986208 Occurrence Handle1:CAS:528:DC%2BD3cXnsVCrurs%3D Occurrence Handle10.1136/gut.47.4.487

    Article  PubMed  CAS  Google Scholar 

  42. KR Reddy JF Colombel D Poulain et al. (2001) ArticleTitleAnti-Saccharomyces cerevisiae antibodies in autoimmune liver disease Am J Gastroenterol 96 252–253 Occurrence Handle11197268 Occurrence Handle1:STN:280:DC%2BD3M7gslGgug%3D%3D Occurrence Handle10.1111/j.1572-0241.2001.03490.x

    Article  PubMed  CAS  Google Scholar 

  43. P Muratori L Muratori M Guidi et al. (2003) ArticleTitleAnti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases Clin Exp Immunol 132 473–476 Occurrence Handle12780695 Occurrence Handle1:CAS:528:DC%2BD3sXlt12itb4%3D Occurrence Handle10.1046/j.1365-2249.2003.02166.x

    Article  PubMed  CAS  Google Scholar 

  44. FF Seibold O Stich R Hufnagl S Kamil M Scheurlen (2001) ArticleTitleAnti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study Scand J Gastroenterol 36 196–201 Occurrence Handle11252413 Occurrence Handle1:STN:280:DC%2BD3MzmvVWlug%3D%3D

    PubMed  CAS  Google Scholar 

  45. InstitutionalAuthorNameBehçet’s Disease Research Committee of Japan (1974) ArticleTitleBehçet’s disease: guide to diagnosis of Behçet’s disease Jpn J Ophthalmol 18 291–294

    Google Scholar 

  46. B Wechsler F Davatchi Y Mizushima et al. (1990) ArticleTitleCriteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease Lancet 335 1078–1080

    Google Scholar 

  47. KJ Kim SK Yang SJ Myung et al. (2002) ArticleTitleDiagnostic value of colonoscopic findings in the differential diagnosis between Crohn’s disease and intestinal Behçet’s disease [abstract] Gastrointest Endosc 55 A263

    Google Scholar 

  48. AJ Greenstein HD Janowitz DB Sachar (1976) ArticleTitleThe extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients Medicine 55 401–412 Occurrence Handle957999 Occurrence Handle1:STN:280:DyaE283ms1Omuw%3D%3D Occurrence Handle10.1097/00005792-197609000-00004

    Article  PubMed  CAS  Google Scholar 

  49. T Matsuda C Tanaka Y Imamura (1999) ArticleTitleBehçet’s disease Med Postgrad 37 350–361

    Google Scholar 

  50. RG Lee (1986) ArticleTitleThe colitis of Behçet’s syndrome Am J Surg Pathol 10 888–893 Occurrence Handle3789253 Occurrence Handle1:STN:280:DyaL2s%2Fntl2isQ%3D%3D Occurrence Handle10.1097/00000478-198612000-00007

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Won Ho Kim M.D..

Additional information

Supported by a faculty research grant of Yonsei University College of Medicine for 2003 (6-2003-0013).

About this article

Cite this article

Choi, C.H., Kim, T.I., Kim, B.C. et al. Anti-Saccharomyces cerevisiae Antibody in Intestinal Behçet’s Disease Patients: Relation to Clinical Course. Dis Colon Rectum 49, 1849–1859 (2006). https://doi.org/10.1007/s10350-006-0706-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10350-006-0706-z

Key words

Navigation